News and Announcements
Altech Chemicals Quarterly Activities and Cashflow Report
- Published October 31, 2016 3:51PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
31st October 2016, ASX Announcement
HIGHLIGHTS
Altech targets increased project debt of US$70 million
- Altech targeting total project debt of US$70m
- Export credit cover component increased to US$60m
- Uncovered debt portion of up to US$10m
- Simplified sole lender structure proposed for the US$70m of debt by KfW IPEX-Bank
Positive pre-assessment of Altech’s US$60m export credit application
- Positive pre-assessment of ECA application by German inter-ministerial committee
- Important milestone in the credit cover application assessment process
- Initiates project detailed due diligence
Appointment of due diligence consultants
- Lenders’ due diligence consultants appointed
- Technical, market and legal due diligence commenced
- Due diligence initiation meeting held in Stuttgart, Germany
- Site visits to Meckering and Johor completed
To view the full announcement, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
